돼지열병 백신 시장 규모 : 제품별, 용도별, 지역 범위별 예측

Swine Fever Vaccine Market Size And Forecast

Swine Fever Vaccine Market size was valued at USD 1.6 Billion in 2024 and is projected to reach USD 2.6 Billion by 2032, growing at a CAGR of 5.1% during the forecast period 2026-2032.

Global Swine Fever Vaccine Market Drivers

The market drivers for the Swine Fever Vaccine Market can be influenced by various factors. These may include:

Growing Swine Population: There is an increasing need for efficient vaccines to prevent diseases like swine fever as the world's pig population continues to grow, particularly in areas like Asia and Latin America.

Government Initiatives and Regulations: To manage and stop swine flu outbreaks, governments and regulatory agencies frequently require vaccination programmes. The market for swine flu vaccinations is driven by laws and policies that are supportive.

Growing Fears Regarding Disease Outbreaks: The swine sector may suffer large financial losses as a result of swine fever outbreaks. The significance of these epidemics is becoming more widely recognised among farmers and other stakeholders, which is driving up demand for vaccinations as a preventive strategy.

Technological developments: The creation of safer and more effective vaccinations is one aspect of the vaccine industry's technological advancements that support market expansion. This covers developments in adjuvant technology, vaccination formulation, and delivery techniques.

Growing Education and Awareness: Market demand is driven by swine farmers' growing understanding of the value of immunisation and illness prevention. Campaigns for education that emphasise the advantages of vaccinations for the prevention and control of disease are important.

Globalisation of the Swine Industry: Disease outbreaks can have a significant impact due to the interconnectedness of the swine industry across nations and regions. Strong immunisation programmes are required, and this globalisation element propels market expansion.

Research and Development Investments: New and better swine fever vaccines are developed as a result of research and development investments made by biotech and pharmaceutical companies. Competitiveness and commercial expansion are fueled by these developments.

Focus on Animal Health and Welfare: As the livestock business places a greater emphasis on animal health and welfare standards, vaccination use to ward off diseases like swine fever is encouraged, which propels market expansion.

Global Swine Fever Vaccine Market Restraints

Several factors can act as restraints or challenges for the Swine Fever Vaccine Market . These may include:

Regulatory Challenges: Due to strict safety standards and regulatory regulations, obtaining regulatory approval for swine fever vaccines can be costly and time-consuming. This procedure may delay the release of new products and serve as a barrier to entry for new competitors.

Limited Knowledge and Education: In certain areas, farmers and livestock owners might not be fully informed of the advantages of swine fever vaccine. This may result in slower adoption rates and decreased demand for vaccinations, especially in regions with fewer swine flu outbreaks.

High Expense of Vaccination Programmes: Farmers and governments may incur significant expenses when putting big swine populations through comprehensive vaccination programmes. Vaccine procurement, administration, and schedule management costs can be a major barrier, particularly for small-scale farms in areas with scarce resources.

Logistical Difficulties: Maintaining the cold chain for vaccine storage and delivery is one logistical problem in the efficient distribution of vaccinations to remote or rural locations. These administrative obstacles may limit vaccination accessibility for all swine farmers, which may have an effect on market penetration.

Efficacy and Safety Concerns: For manufacturers, the effectiveness and safety of swine flu vaccinations are paramount. The effectiveness of vaccines against various virus strains, possible side effects, and long-term immunity are some of the issues that can affect producer trust in vaccination programmes and adoption rates.

Competitive Market Environment: Price wars and product differentiation are two examples of the competitive pressures that can arise from the existence of several vaccine producers and products on the market. The competitive landscape could limit the expansion of individual vaccine suppliers and affect the general dynamics of the market.

Trade Barriers and Export Issues: Outbreaks of swine fever may result in trade restrictions on pig products originating from impacted areas. Because producers would be hesitant to invest in immunisation programmes due to doubts about market access and export potential, this could have an indirect effect on the demand for swine fever vaccinations.

Global Swine Fever Vaccine Market Segmentation Analysis

The Global Swine Fever Vaccine Market is segmented on the basis of Product, Application, and Geography.

Swine Fever Vaccine Market, By Product

• Tissue Culture Origin
• Cell Line Origin

Based on Product, The market is segmented into Tissue Culture Origin and Cell Line Origin. The Tissue Culture Origin segment is anticipated to dominate the Global Swine Fever Vaccine Market. The US biopharmaceutical industries heavily rely on cell culture for tissue culture, drug research, and vaccine manufacture. The segment is expected to develop significantly since tissue culture is vital in the traditional Swine Fever Vaccine.

Swine Fever Vaccine Market, By Application

• Government Tender
• Market Sales

Based on Application, The market is segmented into Government Tender and Market Sales. The Government Tender segment is anticipated to dominate the Global Swine Fever Vaccine Market. Due to the government's intense attention on preventing the spread of classical swine disease, a government tender for the sale of the vaccine is set.

Swine Fever Vaccine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global Swine Fever Vaccine Market is classified into North America, Europe, Asia Pacific, And Rest of the world. North America will hold the largest Global Swine Fever Vaccine Market. The US supplied the largest market share in the North American market for classical Swine Fever Vaccines throughout the forecast period. The region's market for traditional Swine Fever Vaccines is expanding due to several factors, including the region's highly developed healthcare system and the significant investment in R&D to create innovative vaccines for various illnesses.

Key Players

• The major players in the Swine Fever Vaccine Market are:
• WINSUN
• Merial
• CAHIC
• Chopper Biology
• MSD Animal Health
• ChengDu Tecbond
• Ceva
• Veterinary
• Ringpu Biology
• Jinyu Bio-Technology
• Institute Pasteur
• TecOn
• Panav Biotech
• Boehringer Ingelheim International

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SWINE FEVER VACCINE MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Swine Fever Vaccine Market Geographical Analysis (CAGR %)
• 3.6 Global Swine Fever Vaccine Market, By Product (USD Million)
• 3.7 Global Swine Fever Vaccine Market, By Application (USD Million)
• 3.8 Future Market Opportunities
• 3.9 Global Market Split
• 3.10 Product Life Line

4 GLOBAL SWINE FEVER VACCINE MARKET OUTLOOK

• 4.1 Global Swine Fever Vaccine Evolution
• 4.2 Drivers
  • 4.2.1 Driver1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL SWINE FEVER VACCINE MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Tissue Culture Origin
• 5.3 Cell Line Origin

6 GLOBAL SWINE FEVER VACCINE MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Government Tender
• 6.3 Market Sales

7 GLOBAL SWINE FEVER VACCINE MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle-East and Africa
  • 7.6.1 UAE
  • 7.6.2 Saudi Arabia
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL SWINE FEVER VACCINE MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Developments
• 8.4 Company Regional Footprint
• 8.5 Company Industry Footprint
• 8.6 ACE Matrix

9 COMPANY PROFILES

• 9.1 Ceva
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Product Benchmarking
  • 9.1.4 Key Developments
  • 9.1.5 Winning Imperatives
  • 9.1.6 Current Focus & Strategies
  • 9.1.7 Threat from Competition
  • 9.1.8 SWOT Analysis
• 9.2 Boehringer Ingelheim International
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Product Benchmarking
  • 9.2.4 Key Developments
  • 9.2.5 Winning Imperatives
  • 9.2.6 Current Focus & Strategies
  • 9.2.7 Threat from Competition
  • 9.2.8 SWOT Analysis
• 9.3 Bioveta
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Product Benchmarking
  • 9.3.4 Key Developments
  • 9.3.5 Winning Imperatives
  • 9.3.6 Current Focus & Strategies
  • 9.3.7 Threat from Competition
  • 9.3.8 SWOT Analysis
• 9.4 Panav Biotech
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Product Benchmarking
  • 9.4.4 Key Developments
  • 9.4.5 Winning Imperatives
  • 9.4.6 Current Focus & Strategies
  • 9.4.7 Threat from Competition
  • 9.4.8 SWOT Analysis
• 9.5 WINSUN
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Product Benchmarking
  • 9.5.4 Key Developments
  • 9.5.5 Winning Imperatives
  • 9.5.6 Current Focus & Strategies
  • 9.5.7 Threat from Competition
  • 9.5.8 SWOT Analysis
• 9.6 Merial
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Product Benchmarking
  • 9.6.4 Key Developments
  • 9.6.5 Winning Imperatives
  • 9.6.6 Current Focus & Strategies
  • 9.6.7 Threat from Competition
  • 9.6.8 SWOT Analysis
• 9.7 CAHIC
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Product Benchmarking
  • 9.7.4 Key Developments
  • 9.7.5 Winning Imperatives
  • 9.7.6 Current Focus & Strategies
  • 9.7.7 Threat from Competition
  • 9.7.8 SWOT Analysis
• 9.8 Chopper Biology
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Product Benchmarking
  • 9.8.4 Key Developments
  • 9.8.5 Winning Imperatives
  • 9.8.6 Current Focus & Strategies
  • 9.8.7 Threat from Competition
  • 9.8.8 SWOT Analysis
• 9.9 MSD Animal Health
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Product Benchmarking
  • 9.9.4 Key Developments
  • 9.9.5 Winning Imperatives
  • 9.9.6 Current Focus & Strategies
  • 9.9.7 Threat from Competition
  • 9.9.8 SWOT Analysis
• 9.10 ChengDu Tecbond
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Product Benchmarking
  • 9.10.4 Key Developments
  • 9.10.5 Winning Imperatives
  • 9.10.6 Current Focus & Strategies
  • 9.10.7 Threat from Competition
  • 9.10.8 SWOT Analysis

10. VERIFIED MARKET INTELLIGENCE

• 10.1 About Verified Market Intelligence
• 10.2 Dynamic Data Visualization